title: Should systemic thrombolytic therapy be considered a first-line treatment in acute pulmonary embolism?
authors.affiliation: Department of Cardiovascular Surgery, Faculty of Medicine, İzmir Katip Çelebi University; İzmir-Turkey. gokalporhan@yahoo.com.
authors.forename: Orhan
authors.initials: O
authors.lastname: Gökalp
authors.forename: Yüksel
authors.initials: Y
authors.lastname: Beşir
authors.forename: Börtecin
authors.initials: B
authors.lastname: Eygi
authors.forename: Gamze
authors.initials: G
authors.lastname: Gökalp
mesh_terms: D005260:Female; D006801:Humans; D007044:Hysterectomy; D011183:Postoperative Complications / Q000175:diagnosis*; D011655:Pulmonary Embolism / Q000175:diagnosis*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*; D020246:Venous Thrombosis / Q000175:diagnosis*
chemical_list: D010959:Tissue Plasminogen Activator